News Archives 

HTC News Archives

News Articles and Links Previously Featured on our Site

• 5/15/24 New Study Shows Long Term Benefits of Gene Therapy for Severe Hemophilia A ajmc.com
• 4/30/24 FDA Approves New Hemophilia B Gene Therapy Product BEQVEZ bleeding.org
• 4/16/24 New Long-Term Data Shows Emicizumab Safe, Effective in Hemophilia A Patients ajmc.com
• 4/12/24 Study Shows Wristband Tracking Activity Improves Quality of Life in Severe Hemophilia Patients hemophilianewstoday.com
• 3/26/24 FDA Approves IXINITY for Use in Children 12 and Under with Hemophilia B bleeding.org
• 3/15/24 ReciBioPharm Teams Up with GeneVentiv to Develop Gene Therapy for All Hemophilia Patients hemophilianewstoday.com
• 2/28/24 FDA Approves First Human Study of CRISPR/Cas9-based Factor 9 Gene Editing Therapy hemophilianewstoday.com
• 2/23/24 Muscle Loss Common in Hemophilia A Patients with Joint Bleeds hemophilianewstoday.com
• 2/7/24 Trial Shows Roctavian, Gene Therapy, Maintains Effectiveness after Seven Years hemophilianewstoday.com
• 1/31/24 NBDF Names Phil Gattone, M.Ed as Next CEO bleeding.org
• 1/17/24 Jivi Safe, Effective for Hemophilia A in Long-term Study hemophilianewstoday.com
• 1/12/24 First US Patient Treated with Hemophilia A Gene Therapy Outside Clinical Trial bleeding.org
• 12/22/23 Three Year Study Shows SerpinPC is Safe and Reduces Bleeds in Hemophilia A & B hemophilianewstoday.com
• 12/20/23 Hemgenix Lowers Bleeding Rates and the Rate of Replacement Therapy hemophilianewstoday.com
• 12/6/23 Dosing Begins in Phase 1/2a Trial of Optimized Gene Therapy for Hemophilia A hemophilianewstoday.com 
• 11/29/23 FDA Grants Dual Designations for Investigational Hemophilia A Therapy bleeding.org
• 11/10/23 Novo Nordisk and Genevant Join Forces to Develop Gene-editing Treatment for Hemophilia A hemophilianewstoday.com
• 11/6/23 Study Looks at Therapeutic Options for Women with VWD and Heavy Menstrual Bleeding hemophilia.org
• 10/13/23 Over Half of Hemophilia Patients Hide Symptoms and Avoid Sharing Negative Impacts hemophilianewstoday.com
• 10/11/23 Study Shows Hemophilia Survival Rate Disparities hemophilia.org
• 9/29/23 FDA Grants Orphan Drug Status to Baudax Bio's TI-168 for Hemophilia A with Inhibitors hemophilianewstoday.com
• 9/8/23 Colorado Man Shares Positive Results from Gene Therapy Treatment cbsnews.com
• 9/6/23 Analysis Shows Preventative Treatment with Extended Half-Life Products Improves Outcomes hemophilianewstoday.com
• 8/17/23 NHF Changes Name to NBDF to Include All Bleeding Disorders hemophilia.org
• 8/9/23 Small Number of Young Patients Experience Severe Bleeds on Hemlibra hemophilianewstoday.com
• 8/2/23 Gene Therapy Roctavian Likely to Arrive in US in August 2023 hemophilianewstoday.com
• 7/28/23 Roche's Gene Therapy Trial of SPK-8011 Moves Forward to Phase 3 hemophilianewstoday.com
• 7/20/23 Recent Studies Show Fitusiran Could Treat Women's Bleeding Disorders managedhealthcareexecutive.com
• 7/19/23 In Non-Severe Hemophilia A, Hemlibra is not as Cost-Effective as Standard Care hemophilianewstoday.com
• 6/29/23 FDA Approves First Gene Therapy for Adults with Severe Hemophilia A fda.gov
• 6/16/23 FDA Will Review Ixinity for Use in Children Under 12 with Hemophilia B hemophilianewstoday.com
• 6/9/23 Early Prophylaxis Leads to Better Outcomes for Hemophilia A Patients hemophilianewstoday.com
• 5/31/23 Pfizer Announces Positive Results from Phase 3 BASIS Study of Marstacimab hemophilia.org
• 5/10/23 Study Shows Female Hemophilia A Patients and Carriers Undertreated hemophilianewstoday.com
• 5/5/23 AstraZeneca, Sernova Join Forces on Cell Therapy Research hemophilianewstoday.com
• 5/4/23 FDA Asks for More Information on Concizumab from Novo Nordisk fiercebiotech.com
• 4/12/23 Survey of HTC Clinicians Shows Changes in Treatment Trends over 22 Years hemophilianewstoday.com
• 4/6/23 Sanofi Announces Results from Two Phase 3 Trials of Fitusiran hemophilia.org
• 3/15/23 Dr. Beth Warren Discusses Differences in Factor and Non-factor Prophylaxis in ASH Publication ashpublications.org
• 3/15/23 New Data:  Hemgenix Reduces Bleeds in Hemophilia B Better than Standard Therapy hemophilianewstoday.com
• 3/8/23 FDA Extends Review of Gene Therapy Roctavian for Hemophilia A hemophilianewstoday.com
• 2/24/23 FDA Approves Efanesoctocog alfa (Altuviiio) to Treat Hemophilia A pharmacytimes.com
• 2/13/23 Emicizumab (Hemlibra) Appears Safe, Effective in Mild or Moderate Hemophilia hematologyadvisor.com
• 2/6/23 Study Shows Efanesoctocog Alfa Prophylaxis Effective in Hemophilia A hematologyadvisor.com
• 2/2/23 Changes Coming to State Medicaid and CHIP Programs hemophilia.org
• 1/13/23 Roctavian Trial Update Shows Most Patients Bleed Free at Three Years hemophilianewstoday.com
• 1/11/23 FDA Clears Test to Monitor Effectiveness of Hemophilia B Treatments hemophilianewstoday.com
• 1/4/23 Pfizer Announces Updates for Investigational Gene Therapy for Hemophilia A hemophilia.org
• 12/16/22 Data Shows SerpinPC Reduces Bleeds for All Hemophilia Types hemophilianewstoday.com
• 12/12/22 Phase 1/2 Study Shows Durability of Investigational Gene Therapy SPK-8011 in Patient with Hemophilia A einnews.com
• 11/22/22 FDA Approves First Gene Therapy for Hemophilia B fda.gov
• 11/08/22 BioMarin Faces Possible Delay for Hemophilia A Gene Therapy biospace.com
• 11/2/22 Study Shows Heart Risk Higher in Less Active Adult Hemophilia Patients hemophilianewstoday.com
• 10/26/22 Real World Study Shows Switch to Kovaltry Safe, Effective for Hemophilia A hemophilianewstoday.com
• 9/30/22 BioMarin Resubmits Hemophilia A Gene Therapy for FDA Approval fiercepharma.com
• 9/30/22 Research Shows Untreated Hemophilia A Bleeds are Common hemophilianewstoday.com
• 9/23/22 Pfizer and Sangamo Gene Therapy Phase 3 Trial to Resume After Pause for Safety Concerns biopharmadive.com
• 9/16/22 FDA Grants Orphan Drug Status to SerpinPC for Hemophilia B hemophilianewstoday.com
• 8/31/22 FDA Grants Priority Review of Efanesoctocog Alfa for Hemophilia A hemophilianewstoday.com
• 8/19/22 Hemlibra Improves Joint Health in Younger Hemophilia A Patients in Trial hemophilianewstoday.com
• 8/4/22 Recombinant von Willebrand Factor prophylaxis May Reduce ABR in Patients with VWD hematologyadvisor.com
• 8/1/22 FDA Approves Rebinyn for Routine Prophylaxis in Patients with Hemophilia B pharmacytimes.com
• 7/18/22 Freeline Shares Positive Data from Gene Therapy Trial hemophilianewstoday.com
• 7/10/22 Sanofi Shares Data from Two Phase 3 Studies fiercebiotech.com
• 7/8/22 NHF Requests Evaluation and Mitigation Study for Pending Gene Therapies hemophilia.org
• 6/10/22 Elocta (Eloctate in the US) Reduced Elbow, Knee Bleeds in Severe Hemophilia A hemophilianewstoday.com
• 6/2/22 Bayer Announces Discontinuation of Kogenate FS hemophilia.org
• 6/1/22 FDA Grants Breakthrough Status to efanesoctocog alfa (BIVV001) for Hemophilia A hemophilia.org
• 5/9/22 Emicizumab Safe, Effective in Hemophilia A Patients with Inhibitors hematologyadvisor.com
• 5/9/22 Arthritis Medicine Helps Prevent FVIII Inhibitors in Animal Study hemophilianewstoday.com
• 5/3/22 FDA Clears Pfizer to Resume Hemophilia Gene Therapy Trial biopharmadive.com
• 4/29/22 Research Shows Eptacog Beta Safe and Effective in Pediatric Patients hemophilia.org 
• 4/20/22 Bone Disorders More Common for Female Hemophilia Carriers and VWD Patients hemophilianewstoday.com
• 4/13/22 Rebinyn Shows Positive Data in Canadian Real World Study hemophilianewstoday.com
• 3/25/22 First US Patient Dosed in Freeline's Hemophilia B Gene Therapy Trial hemophilia.org
• 3/21/22 Gene Therapy Roctavian Safely Raises FVIII Levels for Hemophilia A Patients in Trial hemophilianewstoday.com
• 3/9/22 Sobi and Sanofi Announce Positive Data for Efanesoctocog Alfa to Treat Hemophilia A prnewswire.com
• 3/2/22 Joint Damage Still Evident in Hemophilia A Patients with Milder Disease hemophilianewstoday.com
• 2/14/22 Vibrating Microbubbles May Improve Gene Therapy Delivery for Hemophilia A hemophilianewstoday.com
• 2/7/22 The Legacy of HTCs: Article from HFA's Dateline Federation-see page 20 hemophiliafed.org
• 2/2/22 Bleeds, Physical Limitations, Affect Severe Hemophilia A Patients Despites Prophylaxis hemophilianewstoday.com
• 1/14/22 Study Shows Low Dose ITI Partially Successful in 80% of Children with Hemophilia A hemophilianewstoday.com
• 1/10/22 BioMarin Announces Positive Results in Gene Therapy Study for Hemophilia A fiercebiotech.com
• 12/31/21 NHF Mournes the Loss of Longtime CEO and Advocate, Val Bias hemophilia.org
• 12/9/21 Update for Hemophilia B Gene Therapy Trial from uniQure and CSL Behring hemophilia.org
• 12/1/21 Hemophilia A Patient Develops Complications in SIG-001 Clinical Trial hemophilianewstoday.com
• 11/23/21 Data Analysis Sheds Light on Bleeding Patterns of Young VWD Patients hemophilia.org
• 11/15/21 Data Finds Fitusiran Reduced Bleeds in Patients with Hemophilia A and B hemophilianewstoday.com
• 11/10/21 FDA Puts Hold on Gene Therapy SB-525 Phase 3 Trial hemophilianewstoday.com
• 11/5/21 Small Study Finds Extended FIX Prophylactic Therapy May Not Ease Pain hemophilianewstoday.com
• 10/18/21 Long-Term Preventative Use of Esperoct Effective in Hemophilia A hemophilianewstoday.com
• 10/11/21 "Reverse Vaccination" May Help Prevent Immune Response hemophilianewstoday.com
• 9/29/21 Study Finds Breakthrough Bleeds Likely for Hemophilia A Patients on Hemlibra hemophilianewstoday.com
• 9/15/21 FDA Restores BeneFIX as Prophylactic for Children with Hemophilia B hemophilianewstoday.com
• 9/13/21 SerpinPC Prevents Bleeds in Hemophilia A and B Patients in Phase 2a Trial hemophilianewstoday.com
• 9/7/21 NHF and HFA Partner to Create "Together Project" hemophilia.org
• 8/6/21 Emicizumab (Hemlibra) May Improve Outcomes for Acquired Hemophilia A hematologyadvisor.com
• 8/4/21 Phase 2 Study Shows Monoclonal Antibody Marstacimab Appears Safe and Effective hematologyadvisor.com
• 8/2/21 Spark Therapeutics Shares Update for Gene Therapy SPK-8011 Trial hemophilia.org
• 7/19/21 New Data for BioMarin's Gene Therapy for Hemophilia A Shared at ISTH prnewswire.com
• 7/9/21 FDA Puts Hold on Sigilon's Hemophilia Cell Therapy Trial fiercebiotech.com
• 7/9/21 ASC Therapeutics to Begin Phase 1/2 Gene Therapy Clinical Trial for Hemophilia A hemophilianewstoday.com
• 6/18/21 Study Analyzes Risk of Inhibitors in Non-Severe Hemophlia A hemophilianewstoday.com
• 6/14/21 Prophylactic Hemlibra May Lower Treatment Costs for Hemophilia A Patients hemophilianewstoday.com
• 6/9/21 Book Contest for Hemophilia B Patients Ends June 30 hemophilianewstoday.com
• 5/25/21 Gene Therapy Trial Data Suggest Efficacy in the Presence of Antibodies hemophilia.org
• 5/19/21 Roctavian, Gene Therapy for Hemophilia A, Shows Potential from Early Data hemophilianewstoday.com
• 5/18/21 First Patient Dosed in Marzeptacog Alfa (MarzAA) Phase 1/2 Study biospace.com
• 5/7/21 Jivi May Prevent Bleeds in Minor Surgery for Hemophilia A Patients hemophilianewstoday.com
• 4/16/21 Dosing Begins for Efanesoctocog Alfa Trial in Boys with Hemophilia A hemophilianewstoday.com
• 4/14/21 Graphic Novel Shares Life with Hemophilia, Dungeons and Dragons hemophilianewstoday.com
• 4/12/21 Jivi Continues to Prevent Bleeds in Severe Hemophilia A Long-term hemophilianewstoday.com
• 4/07/21 Study Shows Continuous Advate IV Effectively Prevented Bleeds in Surgery hemophilianewstoday.com
• 3/31/21 Investigation Shows that Gene Therapy AMT-061 Unlikely to Have Caused Liver Tumor hemophilianewstoday.com
• 3/12/21 Genentech Updates Hemlibra Labeling hemophilia.org
• 3/10/21 BioMarin's Roctavian, Gene Therapy for Hemophilia A, Gets FDA Regenerative Medicine Advanced Therapy Status hemophilianewstoday.com
• 2/24/21 Nuwiq Shows a Low Risk of Developing Inhibitors in Hemophilia A Trial hemophilianewstoday.com
• 2/19/21 FDA puts Efanesoctocog Alfa on Fast Track Designation to treat Hemophilia A hemophilianewstoday.com
• 2/17/21 Recent Study Shows Hemlibra Can Help Manage Acquired Hemophilia A hemophilianewstoday.com
• 1/29/21 Study Shows Esperoct Highly Effective as Prophylaxis Treatment for Hemophilia A hemophilianewstoday.com
• 1/25/21 BioMarin Shares Positive Phase 3 Data for valactocogene roxaparvovec, Gene Therapy for Hemophilia A hemophilia.org
• 1/21/21 CSL Behring Issues Voluntary Recall of Mononine hemophilia.org
• 1/18/21 Study Suggests Eloctate Induces Faster immune Tolerance than other Regimens hemophilianewstoday.com
• 1/13/21 Phase 3 Trial Shows Sustained Drop in Bleeding Rates for Roctavian, Gene Therapy for Hemophilia A hemophilianewstoday.com
• 12/29/20 NHF Shares Information about COVID-19 Vaccines hemophilia.org
• 12/20/20 FDA Puts Clinical Hold on uniQure's Hope B Trial hemophilia.org
• 12/8/20 Updated Phase 1/2 Gene Therapy Study Data Presented at ASH hemophilia.org
• 12/7/20 MarzAA for Hemophilia A or B with Inhibitors Given Fast Track Status from FDA hemophilianewstoday.com
• 11/20/20 UniQure Shares positive Data from AMT-061 Gene Therapy Trial for Hemophilia B hemophilianewstoday.com
• 11/11/20 Study Finds Passive Stretching, Manual Therapy Helps Joints of Hemophilia Patients hemophilianewstoday.com
• 11/3/20 Results Published from Patient Satisfaction Survey Show Positive Reviews of HTCs Nationwide hematologyadvisor.com
• 10/26/20 Data Shows Hemlibra Improves Quality of Life for Children with Hemophilia A hemophilianewstoday.com
• 10/23/20 Study Finds Good Long Term Outcomes After Knee Replacements for Hemophilia Patients hemophilianewstoday.com
• 10/12/20 NIH Awards$1.5M Grant to DNA Medicine Institute to Develop Rapid Fingerstick Test for Factor FVIII 360dx.com
• 10/7/20 First Participant Dosed in Phase 3 Study for Pfizer and Sangamo Gene Therapy pfizer.com
• 10/2/20 CSL Behring States Stimate Will Not Be Resupplied Until 2022 hemophilia.org
• 9/21/20 CSL Behring Will Discontinue Mononine for Hemophilia B hemophilianewstoday.com
• 9/17/20 Genentech Provides Update on Particles in Hemlibra wfh.org
• 9/17/20 Sanofi's BIVV001 Phase 1/2 Trial Results Show Promise hemophilia.org
• 8/19/20 FDA Rejects BioMarin's Gene Therapy for Hemophilia A fiercebiotech.com
• 7/22/20 CSL Behring and Ferring Have Issued a Recall of Stimate hemophilia.org 
• 7/20/20 Data from Biopsy Study of BioMarin's Gene Therapy Shows Positive Results hemophilianewstoday.com
• 7/20/20 Gene Therapy from BioMarin Could be the Most Expensive US Drug Ever npr.org
• 7/17/20 Phase 1/2 Trial of Gene Therapy for Hemophilia B Shows Promise hemophilianewstoday.com
• 7/15/20 Data Shows Hemlibra Continues to Maintain a Favorable Safety Profile hemophilianewstoday.com
• 7/13/20 Roche Posts Update on Hemophilia A Gene Therapy Data fiercebiotech.com
• 6/3/20 Early Treatment Linked to Reduced Joint Damage in Young Adults with Severe Hemophilia A ashpublications.org
• 5/13/20 BioMarin’s Gene Therapy for Hemophilia A Remains on Track for US Approval hemophilianewstoday.com
• 5/4/20 Study Finds Prophylaxis is Better than On-Demand Treatment for Adults with Hemophilia A hemophilianewstoday.com
• 5/1/20 NHF Adjust Annual Conference to Virtual Resource hemophilia.org
• 4/15/20 New Bloodstream Media Podcast Tackles Pain bloodstreammedia.com
• 4/1/20 FDA Approves Sevenfact for Hemophilia A and B With Inhibitors fda.gov
• 3/3/20 Medexus Acquires IXINITY from Aptevo hemophilia.org
• 3/3/20 MASAC Addresses Concerns about Coronavirus and Bleeding Disorders hemophilia.org
• 2/28/20 Survey of Healthcare Providers Shows Obesity a Likely Factor in Joint Bleeds hemophilianewstoday.com
• 2/24/2020 Valrox, Gene Therapy for Hemophilia A, Accepted for Priority Review hemophilianewstoday.com
• 2/10/2020 Novo Nordisk Launches Esperoct, Long-Acting Recombinant for Hemophilia hemophilia.org
• 2/6/2020 Bloodstream Mini with Dr. Laura Fox, Physical Therapist podcasts.apple.com
• 1/28/2020 FDA Updates Guidelines for Gene Therapy Treatments centerforbiosimilars.com
• 1/24/2020 New Study Suggests Primary Postpartum Hemorrhage Remains a Challenge for Type 3 VWD Patients hemophilia.org
• 1/20/2020 BioMarin Says Gene Therapy May Cost up to $3 Million hemophilianewstoday.com
• 1/17/2020 Dr. Leonard A. Valentino chosen as the new President and CEO of NHF hemophilia.org
• 1/8/2020 Sangamo Transfers Development of SB-525 Gene Therapy to Pfizer hemophilia.org
• 12/23/2019 Dr. Christopher Ng Shares Research Update with “Ask The Expert” Podcast bloodstreammedia.com
• 12/10/2019 Emicizumab May Yield Improvements in Joint Health in Hemophilia Patients hematologyadvisor.com
• 12/10/2019 UniQure and Pfizer share updates on gene therapy trials for hemophilia B biopharmadive.com
• 12/9/2019 Takeda and Enzyre Partner to Develop Home Blood Test for Hemophilia Patients hemophilianewstoday.com
• 12/8/2019 Study Presented at ASH Examines Adherence Rates for Hemophilia Patients Using Emicizumab pharmacytimes.com
• 12/7/2019 Sangamo Shares Data for Gene Therapy Study on SB-525 for Hemophilia A businesswire.com
• 12/6/2019 New guidelines from MASAC on Bleeding Disorder Patients in the ER hemophilia.org
• 11/25/2019 Paradigm Shift in Hemophilia Treatment, an Interview with Dr. Michael Wang bloodstreammedia.com
  
• 10/10/19 Application Deadline for NHF's National Youth Leadership Institute​ is Oct 31 hemophilia.org
• 10/08/19 FDA Approves Wilate for Hemophilia A in Adult and Adolescent Patients businesswire.com
• 10/07/19 Genentech Issues Statement on Hemlibra Particles; MASAC Responds hemophilia.org
• 9/13/19 Freeline's Gene Therapy for Hemophilia B Shows Promising Phase 1/2 Results hemophilianewstoday.com
• 9/10/19 Study Shows Hemophilia 3 Times as Prevalent in Men as Originally Thought globalnews.ca
• 9/10/19 BioMarin Explains Phase 3 Results for Hemophilia A Gene Therapy Trial biopharmadive.com
• 9/9/19 Hemlibra Given with Immune Tolerance Induction Safely Treats Children hemophilianewstoday.com
• 8/28/19 FDA Grants Orphan Drug Designation to SIG-001 for Hemophilia A healio.com
• 7/9/19 Positive Data from Multiple Studies Shared about Hemlibra at ISTH Congress biospace.com
• 7/8/19 New Results Presented on​ Catalyst's MarzAA for Hemophilia A or B pharmaphorum.com
• 7/8/19 BioMarin Announces Plans to Submit to FDA for Gene Therapy Marketing Authorization prnewswire.com
• 7/7/19 Bioverativ Presents Positive Data from Completed Phase 1/2 EXTEN-A Study pipelinereview.com
• 7/6/19 Sangamo and Pfizer Announce Updated Phase 1/2 Results for Gene Therapy pipelinereview.com
• 7/6/19 UniQure Announces Positive Follow Up Data from Gene Therapy Studies globenewswire.com
• 7/1/19 Study Finds Jivi May Protect Hemophilia A Patients Longer than Eloctate hemophilianewstoday.com
• 5/30/19 Six Ways for Young Adults to Make Adherence Easier hemaware.org
• 5/29/19 Bayer Joins WFH to Help Hemophilia Patients in Developing Countries hemophilianewstoday.com
• 5/28/19 BioMarin Shares Data for Gene Therapy Before FDA Submission biopharmadive.com
• 5/20/19 Being​ Fin's Mom: Life after your newborn has a stroke 9news.com
• 5/15/19 New Data for uniQure's Phase 2 Trial for AMT-061, Hemophilia B Gene Therapy hemophilianewstoday.com 
• 5/9/19 Signs of Stroke in Babies and Toddlers youtube.com
• 5/8/19​ Talking About School Shootings childrenscolorado.org
• 5/1/19 Why We Can't Forget Children During Stroke Awareness Month pediatricstrokewarriors.org​
• 4/23/19 Accumulator Program Update: Washington Tells Insurers "Not So Fast" hemob.org
• 4/17/19 Believe Limited Releases Soundtrack for Musical and Launches New Programs benzinga.com
• 4/5/19 Catalyst Biosciences Enrolling for Phase 2b Trial for Hemophilia B Treatment hemophilianewstoday.com
• 4/2/19 NHF Joins PAN to Offer More Support for Bleeding Disorder Patients hemophilia.org
• 4/2/19 New Interim Data from Sangamo and Pfizer on Gene Therapy for Hemophilia A biospace.com​
• 3/26/19 Study Finds Benefit from Extended Half-Life Products for Hemophilia A Patients prnewswire.com​
• 3/25/19 Pharmacokinetic Dosing May Benefit Hemophilia A Patients Study Finds hemophilianewstoday.com
• 3/13/19 Precision BioLogic's Inhibitor Screening Kit Cleared by FDA for Sale in US prnewswire.com
• 2/25/19 Roche to Buy Spark Therapeutics for $4.3 Billion fiercepharma.com
• 2/20/19 FDA Approves Novo Nordisk's Esperoct for Hemophilia A biospace.com
• 1/29/19 Pool More than a Safeguard for Sun Devil Swimmer Elijah Warren thesundevils.com​
• 1/23/19 Study Finds Bleeding Tool Useful to Assess Hemophilia Severity hemophilianewstoday.com
• 1/21/19 Physical Therapists Rank Risks of Activities for Hemophilia Patients hemophilianewstoday.com
• 1/14/19 Non-Profit Save One Life Welcomes Chris Bombardier as New Executive Director prweb.com
• 1/11/19 Study Finds Hepatitis C a Major Predictor of Liver Cancer in Hemophilia Patients hemophilianewstoday.com
• 1/7/19 Phase 3 Study Shows Novoeight Safe and Effective Over Long Term hemophilianewstoday.com
• 12/17/18 Sangamo Treats 1st Patient in Trial of In Vivo Genome Editing for Hemophilia B prnewswire.com​
• 12/3/18 Roche Shares Positive Data for Hemlibra at American Society of Hematology roche.com
• 12/2/18 Data on Eloctate and Alprolix Show Efficacy and Safety over Four Years prnewswire.com
• 12/2/18 Spark Announces Updated Data for Gene Therapy SPK-8011 for Hemophilia A globenewswire.com
• 11/12/18 BioMarin Sponsors "Hemophilia:  The Musical" with Teens from Around the US fiercepharma.com
• 11/7/18 Local Carson McCabe Interviewed on 9News After Being Chosen for Musical. 9news.com​
• 10/29/18 Arvada Teen Performs in Musical about Bleeding Disorders in NYC arvadapress.com​
• 10/24/18 Mimicry Not Replacement: Molecular Engineering Transforms Outlook hematology.org
• 10/23/18 AAV Gene Therapy Successfully Given Again to Dogs in Model of Hemophilia A hemophilianewstoday.com
• 10/23/18 NHF Publishes Review after 70th Annual Bleeding Disorders Conference pageturnpro.com
• 10/4/18 FDA Approves Hemlibra for Hemophilia A Patients Without Inhibitors bloomberg.com
• 9/18/18 Many Watching FDA for Ruling on Subcutaneous Formulation of Hemlibra biospace.com
• 9/14/18 Liver Transplant Highly Benefits, but May Not Fully Cure, Hemophilia hemophilianewstoday.com
• 9/10/18 Study Finds More Hemophilia Patients are Overweight & Obese hemophilianewstoday.com​
• 8/30/18 Genentech Shares Positive Phase III Results for Hemlibra in NEJM biospace.com
• 8/30/18 FDA Approves Jivi, a New Hemophilia Treatment prnewswire.com
• 8/16/18 Catalyst Provides Update on Phase 2/3 Trial for Hemophilia with Inhibitors biopharmadive.com
• 8/13/18 They Thought Hemophilia was a "Lifelong Thing." They May Be Wrong nytimes.com
• 8/8/18 Review Finds Multiple Factors Contribute to Inhibitors in Hemophilia hemophilianewstoday.com
• 8/8/18 Spark Updates Data for Hemophilia A Gene Therapy Trial hemophilia.org
• 7/30/18 Cost Analysis Compares Gene Therapy and Prophylaxis Care for Hemophilia A hemophilianewstoday.com
• 7/16/18 Pfizer Initiates Phase 3 Study for Hemophilia​ B Gene Therapy businesswire.com
• 7/11/18 FDA Issues New Guidance for Advancing Gene Therapies, Including Hemophilia fda.gov
• 7/9/18 Study Finds Hemophilia Patients Still at Risk for Cardiovascular Disease hemophilianewstoday.com
• 7/2/18 NHF Collaborating with ASH, ISTH, and WFH to Create Guidelines on VWD Care hemophilia.org
• 6/28/18 UniQure Enrolls First Patient in Phase 3 HOPE-B Study​ of AMT-061 globenewswire.com
• 6/18/18 Catalyst Biosciences Shares Update on CB2679 Program for Hemophilia B globenewswire.com
• 6/5/18 FDA Grants Priority Review to Emicizumab for Hemophilia A Without Inhibitors mdmag.com
• 5/28/18 Octapharma Presents Data on Nuwiq for Hemophilia A Patients businesswire.com​
• 5/22/18 Spark and Pfizer Share Data from SPK-9001 Trial for Hemophilia B Patients pfizer.com
• 5/22/18 FDA to Speed Path to Approval for Some Gene Therapies-Starting w/Hemophilia statnews.com
• 5/22/18 Data from Hemlibra Trials Shared at WFH World Congress pipelinereview.com
• 5/21/18 Bioverativ Shares Data on BIVV001 for Hemophilia A Patients bioverativ.com
• 5/15/18 BioMarin Announces First Patient Dosed in Gene Therapy Study for Hemophilia A Patients with AAV5 Antibodies prnewswire.com
• 5/8/18 Takeda Secures Takeover of Shire with $62 Billion Deal biopharmadive.com
• 4/30/18 Study Suggests Prophylaxis Could Reduce Hospitalizations for VWD Patients hemophilia.org​
• 4/22/18 Sharon Funk Discusses PT and Bleeding Disorders in Ask the Expert Podcast bloodstreamexpert.com
• 4/17/18  FDA Grants Breakthrough Therapy Designation for Hemlibra bioscience.com
• 3/26/18 Dr. Marilyn Manco-Johnson Talks Gene Therapy in Ask The Expert Podcast bloodstreamexpert.com​
• 3/20/18 CSL Behring Discontinues Monoclate-P hemophilia.org
• 3/12/18 Sharon Funk and Lynn Magnuson Honored for Years of Service with CU Medicine cuanschutztoday.org
• 3/5/18 Miracle of Hemophilia Drugs Comes at a Steep Price npr.org
• 3/1/18 Blood Journal Article Indicates Hemophilia Gene Therapy is Effective and Safe bloodjournal.org
• 3/1/18 NHF Helps Launch Campaign to Encourage Patients to Take Survey on HTC Care hemophilia.org
• 2/19/18 Barry Haarde, Hemophilia Advocate and Inspiration, Passes Away at 52 blog.kelleycom.com​
• 2/17/18 Babies Who Suffer Stroke Regain Language Function in Opposite Side of Brain sciencedaily.com
• 2/13/18 Hemophilia Gene Therapies Show Promise jamanetwork.com
• 1/10/18 Catalyst Biosciences Given Permission to Change Trial Length for CB 2679d hemophilianewstoday.com
• 1/10/18 NY Times Shares Patient Voices: Hemophilia nytimes.com​
• 1/9/18 Alnylam and Sanofi Partner to Treat Rare Disorders hemophiliafed.org
• 1/6/18 Chris Bombardier Completes Seven Summits by Climbing Mt. Vinson facebook.com
• 12/11/17 BioMarin Shares New Data on Gene Therapy for Hemophilia A streetinsider.com
• 12/8/17 Gene Therapy Shows Promise for Hemophilia B news-medical.net
• 12/5/17 Shire to Develop New Way to Administer Hemophilia Medications reuters.com
• 12/4/17 2017 NHF/Novo Nordisk Career Development Award Goes to Dr. Chris Ng hemophilia.org
• 11/21/17 Startup Could Bring Back Vioxx for Hemophilia Patients chicoer.com
• 11/16/17 FDA Approves Hemlibra (Emicizumab) for Hemophilia A with Inhibitors gene.com
• 11/9/17 Alnylam Announces Successful​ Outcome Following FDA Meeting on Fitusiran seekingalpha.com
• 11/8/17 Hemophiliac Readies for Climb of Mt. Vinson, Final in 7 Summits hemophilianewstoday.com
• 11/6/17 Study Shows Positive Outcomes for Hemophilia A Patients hemophilia.org
• 10/30/17 FDA Accepts Beyer's Biologics License Application for BAY 94-9027 prnewswire.com​
• 10/27/17 FDA Grants BioMarin Investigational New Drug Status to BMN 270 hemophilianewstoday.com
• 10/23/17 FDA Grants Orphan Drug Designation to Shire's SHP654 for Hemophilia A raredr.com
• 10/19/17 UniQure Announces New Study for Hemophilia B Gene Therapy Program globenewswire.com
• 10/9/17 Hemophilia A Study Shows Potential to Reduce Inhibitors hemophilianewstoday.com
• 10/2/17 BloodStream Podcast-Factor Revolution: 60 Years of Hemophilia bloodstream.libsyn.com
• 9/28/17 How to Talk to Kids About Tragic Events childrenscolorado.org
• 9/28/17 NHF Collects Funds to Support Puerto Rico Patients with Bleeding Disorders hemophilia.org
• 9/28/17 Urgently Needed Hemophilia Drugs Delivered to Puerto Rico Pediatric Hospital directrelief.org
• 9/26/17 Catalyst Biosciences Granted FDA Orphan Drug Designation for CB2679 businessinsider.com
• 9/16/17 New Section of Memorial Dedicated to People w/Hemophilia who Died of AIDS sfchronicle.com
• 9/11/17 "How do you thank someone for saving your life?" bostonglobe.com
• 9/9/17 Bioverativ and Bicycle Join to Develop Drugs for Hemophilia labiotech.eu
• 9/7/17 Seven Ways You Can Prepare for Emergencies hemophilia.org
• 9/7/17 Alynlam's Hemophilia Program on Hold Following Patient Death raredr.com
• 9/6/17 Catalyst Biosciences Announces Positive Clinical Data for Hemophilia B Trial globenewswire.com
• 8/31/17 Bayer Submits BLA for Long-Acting Factor VIII for Hemophilia A genengnews.com
• 8/24/17 Pfizer Launches Innovative Technologies for Hemophilia Patients raredr.com
• 8/24/17 FDA Grants Priority Review of Genentech's Emicizumab for Hemophilia A businesswire.com
• 8/15/17 NHF, HFA and Hemophilia of Iowa File Hemophilia Discrimination Complaint prnewswire.com​
• 7/20/17 Regis Jesuit's Elijah Warren Eager to Get Going at ASU aurorasentinel.com
• 7/14/17 Hemophilia B Pediatric, Adult Patients Benefit from Idelvion hemophilianewstoday.com
• 7/12/17 BioMarin, Spark, Raising the Stakes for Hemophilia biopharmadive.com
• 7/11/17 BioMarin Announces Results from Study of BMN 270 to Treat Hemophilia A streetinsider.com
• 7/11/17 UniQure Presents Data on Hemophilia B Gene Therapy Research pharmiweb.com
• 7/10/17 Promising New Data from Alnylam and Sanofi for Fitusiran statnews.com
• 7/6/17 NEJM Publishes Latest Update on HAVEN 1 Trail (Emicizumab) nejm.org
• 7/6/17 Shire Submits Application to FDA for Gene Therapy for Hemophilia A iii.co.uk​
• 6/23/17 FDA Approves Bevyxxa to Prevent VTE in At-Risk Patients globenewswire.com
• 6/12/17 Man with Severe Hemophilia Talks about Climbing Mount Everest 9news.com
• 6/11/17 FDA Accepts Investigational New Drug Application for Hemophilia A Treatment raredr.com
• 6/1/17 Iowa Teen's $1 Million-Per-Month Illness No Longer a Secret msn.com​
• 5/31/17 FDA Approves Novo Nordisk's Rebinyn to Treat Hemophilia B prnewswire.com​
• 5/22/17 Climber from Colorado with Hemophilia Summits Mt. Everest 9news.com
• 5/12/17 Sangamo and Pfizer to Collaborate on Hemophilia A Gene Therapy pharmabiz.com
• 5/10/17 Dimension Therapeutics Discontinues Development of DTX101 pipelinereview.com
• 5/8/17 FDA Grants Orphan Drug, Fast Track to 2 Hemophilia Products hemophilianewstoday.com
• 5/2/17 Man from Colorado with Hemophilia is Making his way up Mt. Everest purpose2play.com
• 4/28/17 Children's Hospital Colorado Highlights Dr. Jorge DiPaola childrenscolorado.org​
• 4/27/17 Prophylaxis Usage Analysis Authored by Dr. Marilyn Manco-Johnson Published bloodjournal.org
• 4/18/17 Roche Reports Positive Results for Phase III HAVEN 2 Study pharmabiz.com​
• 4/17/17 Thousands Reach Out After Perth Woman's Bleeding Disorder Story abc.net.au
• 4/17/17 CDC Updates Site on Preventing Inhibitors in Bleeding Disorders cdc.gov
• 4/11/17 Catalyst Biosciences Reaches Milestone to Advance Factor IX Program globenewswire.com
• 3/31/17 Ryan White Letters to go on Display cbs4indy.com​
• 3/21/17 Amy Board of NHF CO and Chris Bombardier Interviewed on Colorado & Company youtube.com
• 3/15/17 Aptevo Therapeutics Announces New IXINITY Supply Available May 2017 globenewswire.com
• 3/13/17 Washington Days Brings Big Crowd to Capitol Hill hemophilia.org
• 3/7/17 CU Anschutz Medical Campus Bus Shuttle a Transit Success cuanschutztoday.org
• 3/2/17 "My Life, Our Future" Repository Opens Data to Researchers raredr.com
• 3/2/17 Chris Bombardier Takes on Mount Everest saveonelife.net
• 3/2/17 Data from Long Term Study of Alprolix to Treat Hemophilia B Published businesswire.com
• 2/13/17 Plant Based Hemophilia Therapy Shows Promise to Reduce Inhibitors news.upenn.edu​
• 2/3/17 New Drugs to Treat Hepatitis C Under Priority Review at FDA pharmaceutical-businessreview.com
• 1/30/17 uniQure's AMT-060 Gains Breakthrough Designation from FDA for Hemophilia B healio.com
• 1/5/17 FDA Clears Sangamo's SB-525 Gene Therapy for Investigational New Drug pipelinereview.com​
• 12/31/16 NBC Checks Back in with Real Life Super Hero Kid "Iron Max" nbcnews.com
• 12/27/16 FDA Approves Adynovate to Treat Children and for Surgeries with Hemophilia A raredr.com
• 12/22/16 Roche's ACE-910 Succeeds in First of Three Final Stages of Clinical Trial bloomberg.com
• 12/20/16 Biogen Approves Spin-off Hemophilia Business Bioverativ thestreet.com
• 12/6/16 NovoSeven Resolved 96.5% of Bleeds in Hemophilia A and B Patients europeanpharmaceuticalreview.com
• 12/5/16 Vonvendi, Treatment for von Willebrand Disease, Meets Endpoints in Study biopharmadive.com
• 12/4/16 Alnylam Shares Positive Data on Fitusiran for Hemophilia Patients w/Inhibitors pipelinereview.com
• 12/3/16 Biogen Presents Updated Data for Eloctate and Alprolix at ASH businesswire.com​
• 12/3/16 uniQure Announces Clinical Data from AMT-060 Phase I/II Trial globenewswire.com
• 12/3/16 CSL Behring Shares New Phase III Analysis of Idelvion for Hemophilia B prnewswire.com
• 12/3/16 Gene Transfer in Spark's Study Sustains Stable Factor Levels in Hemophilia B healio.com
• 11/30/16 CRISPR Used for the First Time to Correct Hemophilia B in Mice pennmedicine.org
• 11/28/16 UT Austin Develops First Capsule to Treat Hemophilia news.utexas.edu
• 11/10/16 NHF Addresses Post-Election Questions on Affordable Care Act and Advocacy hemophilia.org
• 11/2/16 Adverse Events in Trial Dent Hopes for Roche Hemophilia Drug reuters.com
• 10/26/16 HFA Produces a Podcast Aimed at Young Adults with Hemophilia buzzsprout.com​
• 10/27/16 To Treat One Rare Blood Disorder, Scientists Exploit Another medicalexpress.com
• 10/18/16 Prescription Benefit Program Changes for Recombinant Clotting Factor Product hemophiliafed.org
• 10/5/16 Virtual Reality Game Makes Infusions Easier on Young Patients newswise.com
• 10/4/16 FDA Warns of Risk of Hepatitis B Reactivating in Patients Treated for Hepatitis C fda.gov
• 9/28/16 Voices of 5000+ Patients: 1st National HTC Survey Experience Webinar youtube.com
• 9/16/16 New Method Identifies Female Carriers of Hemophilia A in Study hemophilianewstoday.com
• 9/11/16 Greeley Tribune Shares Ride the Rockies Experience of HTC Patient greeleytribune.com
• 9/8/16 PPTA Updates News Release About Zika Virus and Blood Supply pptaglobal.org
• 9/6/16 Sangamo BioSciences Receives Orphan Drug Status for SB-FIX prnewswire.com
• 8/30/16 National Hemophilia Foundation Videos Win National Awards hemophilia.org 
• 8/22/16 Bloodstream Podcast Recaps NHF Annual Meeting and WFH World Congress bloodstreampod.com
• 8/15/16 Additional Lots of Kogenate FS Included in Voluntary Recall hemophilia.org
• 8/11/16 Extension of Voluntary Recall for Additional Lots of Helixate FS hemophilia.org
• 8/9/16 Vonvendi Now Available to Treat Adults with von Willebrand Disease shire.com
• 8/9/16 Biogen Announces Hemophilia Spin-off Company as Bioverativ fiercebiotech.com
• 8/4/16 Bruising Uncommon in Very Young Children with Blood Disorders hemophilianewstoday.com 
• 8/1/16 UniQure Shares Updated Clinical Data from Gene Therapy Trial of AMT-060 hemophilianewstoday.com
• 7/29/16 Hemophilia Not Slowing Regis Jesuit Swim Star Warren aurorasentinel.com
• 7/29/16 Roche Reports Encouraging Data for Emicizumab at WFH Congress endpts.com
• 7/27/16 BioMarin Shares Dramatic Results from Gene Therapy Research forbes.com
• 7/27/16 Sangamo BioSciences Reveals New Gene Therapy Development Program fiercebiotech.com
• 7/27/16 CSL Behring Presents Data for Afstyla in Adolescents and Children prnewswire.com
• 7/26/16 Novo Nordisk Shares Data of Psychosocial Impact on People with Hemophilia B prnewswire.com
• 7/26/16 CSL Behring Presents Phase III Data for Idelvion to Treat Hemophilia B cslbehring.com
• 7/25/16 Alnylam Pharma Announces Positive Data for Fitusiran Phase I Study streetinsider.com
• 7/25/16 CSL Behring Announces Voluntary Recall of Two lots of Helixate FS hemophilia.org
• 7/25/16 Bayer Announces Voluntary Recall of Two Lots of Kogenate FS hemophilia.org
• 7/21/16 Spark Therapeutics and Pfizer Gain FDA Breakthrough Designation for SPK-9001 streetinsider.com
• 7/8/16 Kovate DVI Shipments on Hold hemophilia.org
• 6/28/16 SIPPET Study & MASAC Recommendations Explained bloodstreampod.com
• 6/28/16 FDA Approves Epclusa to Treat Hepatitis C fda.gov
• 6/22/16 New Podcast for Bleeding Disorders Launches bloodstreampod.com
• 6/16/16 Analysis Published in Blood Reviews Outcomes bloodjournal.org
• 6/14/16 Drug Makers Work to Woo Kids with Hemophilia statnews.com
• 6/13/16 Spark Therapeutics Releases Positive Data on Gene Therapy ir.sparktx.com
• 6/13/16 UniQure Presents Data from Gene Therapy Trail for Hemophilia B pipelinereview.com
• 5/28/16 FDA Approves CSL Behring's Afstyla to Treat Hemophilia A pharmabiz.com
• 5/26/16 SIPPET Study Results Published in New England Journal of Medicine hemophilia.org
• 5/13/16 CSL Behring's Idevlion Receives Marketing Exclusivity from FDA pharmabiz.com
• 5/9/16 US Health Officials Brace for Battle with Zika healthfinder.gov
• 5/3/16 Biogen Announces Intent to Spin off its Hemophilia Business media.biogen.com
• 4/22/16 Dept of Health & Human Services Supports Study of Zika Blood Screening Test hhs.gov
• 4/20/16 BioMarin Provides Encouraging Update in Hemophilia A Gene Therapy Program rttnews.com
• 4/16/16 Woman Fights for Females Living with Bleeding Disorders abc.net.au
• 4/14/16 Biogen Joins in Celebration of World Hemophilia Day businesswire.com
• 4/13/16 CSL Behring Marks World Hemophilia Day by Donating Medications prnewswire.com
• 3/28/16 Research on Mice Shows Concurrent Influenza Vaccination Reduces Inhibitors bloodjournal.org
• 3/20/16 Youth is Served in Stroke Save uchealth.org
• 3/16/16 Study of Hemophilia Care Reveals Progress, Ongoing Health Needs hematology.org
• 3/7/16 FDA Approves Idelvion to Treat Hemophilia B healio.com
• 3/1/16 Dr. Holbrook Khort, Hemophiliac Who Made Condition a Crusade, Dies at 38 nytimes.com
• 3/1/16 BioMarin Receives Orphan Drug Status from FDA for First AAV-Factor VIII Gene Therapy, BMN 270, to Treat Hemophilia A globenewswire.com
• 2/27/16 Baxalta Submits sBLA for Adynovate to Treat Pediatric Hemophilia A Patients pharmabiz.com
• 2/4/16 NHF Provides Updates on Actions Being Taken to Keep Blood Supply Safe hemophilia.org
• 2/4/16 WFH Releases Statement on Zika Virus and Plasma Derived Treatment Products wfh.org
• 2/4/16 HFA Provides Updates and Info on Zika Virus and the Blood Supply hemophiliafed.org
• 2/3/16 Red Cross Takes Steps to Prevent Zika Virus in Blood Supply news.health.com
• 1/28/16 FDA Approves Zepatier to Treat Chronic Hepatitis C Genotypes 1 and 4 fda.gov
• 1/27/16 Gilead Faces Scrutiny, Lawsuits Over Pricing of Treatments for AIDS/Hep C biospace.com
• 1/27/16 March Officially Named Bleeding Disorders Awareness Month hemophilia.org
• 1/20/16 Gene Therapy Research Shows Potential for Long Lasting Treatment eurekalert.org
• 1/13/16 Hemophilia Patient or Drug Seller? Dual Role Creates Ethical Quandary nytimes.com
• 1/11/16 Drug Maker Shire to Buy Baxalta for $32 Billion reuters.com
• 1/6/16 Gilead Snags Priority Review for Pangenotype Hepatitis C Combo Treatment biopharmadive.com
• 1/4/16 Octapharma's NUWIQ Now Available in the US to Treat Hemophilia A businesswire.com
• 12/21/15 Sernova Awarded Grant to Fund Development of Cell-Based Treatment for Hemophilia A sernova.com
• 12/17/15 SIPPET Results Presented at ASH 2015 hemophilia.org
• 12/16/15 Arsia & Biogen Unite to Develop Subcutaneous Method for Delivering Hemophilia Medications bostonglobe.com
• 12/08/15 FDA Approves Vonvendi as First Recombinant von Willebrand Factor Treatment fda.gov
• 12/08/15 New Data Shows Eloctate & Alprolix May Manage Target Joint Bleeds and Maintain Low Annual Bleeding Rates for Severe Hemophilia A & B pharmiweb.com
• 12/07/15 NHF CO Selects Denver Brandworks to Expand "Backpacks & Bleeders" Program pr.com
• 12/07/15 Positive Data for Alnylam's Once-Monthly Fitusiran (ALN-AT3) to Treat Hemophilia A & B businesswire.com
• 12/07/15 New Data Presented by Sangamo BioSciences on SB-FIX, Clotting Protein  to Treat Hemophilia B prnewswire.com
• 12/07/15 Baxalta Shares Updates on Trial of ADYNOVATE to treat Hemophilia A streetinsider.com
• 12/07/15 CSL Behring Presents Data From Phase III Trial for Long Acting rIX-FP to Treat Hemophilia B prnewswire.com
• 12/02/15 FDA Accepts New Drug Application for AbbVie's Once-a-day VIEKIRA PAK to Treat Hepatitis C Genotype 1 prnewswire.com
• 12/01/15 FDA Clears Investigational New Drug Application by Sangamo BioSciences for SB-FIX to Treat Hemophilia B prnewswire.com
• 12/01/15 Study of ACE910 Suggests Treatment May Result in Fewer Injections to Treat Hemophilia A hematology.org
• 11/13/15 FDA Approves Adynovate for Hemophilia A fda.gov
• 11/2/15 BDI Pharma, Inc. Selected as Authorized Distributor of Coagadex prnewswire.com
• 11/2/15 Research at Rice University Yields New Answers about Factor VIII news.rice.edu
• 10/20/15 FDA Approves First Factor X Concentrate to Treat Patients with Bleeding Disorder fda.gov
• 10/19/15 Lettuce Can Make Drugs That Don't Require Refrigeration futurity.org
• 10/8/15 Alnylam Pharma Announces Phase 1 Study with ALN-AT3 to Treat Bleeding Disorders streetinsider.com
• 10/8/15 Octapharma Licenses Glycotope Platform; Takes Stake in Company genengnews.com
• 10/2/15 Infections May Temporarily Increase Children's Stroke Risk biosciencetechnology.com
• 9/30/15 New Hepatitis C Combination Shows Positive Results Across All Genotypes hcplive.com
• 9/28/15 BioMarin Enrolls Patients in Gene Therapy Trial for BMN 270 to Treat Hemophilia A globenewswire.com
• 9/28/15 NHF Announces Comprehensive Care Sustainability Collaborative (CCSC) hemophilia.org
• 9/17/15 FDA Grants Fast Track Designation for Dimension's DTX101 to Treat Hemophilia B  dimensiontx.com
• 9/16/15 FDA Approves Octapharma's NUWIQ to Treat Hemophilia A thepharmaletter.com
• 9/10/15 FDA Accepts Dimension's DTX101 as Investigational New Drug and Grants Orphan Designation to Treat Hemophilia B businesswire.com
• 9/4/15 FDA Grants Breakthrough Therapy Designation to Genentech's ACE910 to Treat Hemophilia A with Factor VIII Inhibitors businesswire.com
• 9/3/15 World Leaders Meet at First World Hepatitis Summit to Discuss Prevention news-medical.net
• 9/1/15 Recombinant FVIII with Extended Half-Life Shown Safe, Effective for Hemophilia A healio.com
• 8/26/15 CSL Behring Enrolling for Study of rVIIa-FP for Hemophilia Patients with Inhibitors news-medical.net
• 8/17/15 Biogen Issues Positive Update on Alprolix Phase III Study for Hemophilia B streetinsider.com
• 8/10/15 Data Supporting Long-Term Safety of Eloctate Published in Haemophilia marketwatch.com
• 8/3/15 Hemophilia Drugs a Big Part of Medicaid Spending doctorslounge.com
• 8/3/15 Engineered Clotting Protein Effective in Severe von Willebrand Disease hematology.org
• 7/28/15 FDA Publishes Drug Shortage Ruling hemophilia.org
• 7/28/15 FDA Accepts CSL Behring's BLA for Hemophilia Therapy pipelinereview.com
• 7/24/15 Bristol-Myers, AbbVie get FDA Approval for Hepatitis C Treatments reuters.com
• 7/24/15 FDA Approves Technivie for Treatment of Chronic Hepatitis C Genotype 4 fda.gov
• 7/24/15 Researchers Find Way to Reverse Clotting Factor Deficiency Triggering Hemophilia A news-medical.net
• 7/12/15 CU Doctor Earns Awards to Research Improving Hemophilia Outcomes denverpost.com
• 7/11/15 Hepatitis Drug Overtakes $1000-per-pill Treatment in Shifting Options for Care mercurynews.com
• 7/1/150 Baxalta Launches as Spinoff of Baxter Aimed at Underserved Conditions businesswire.com
• 7/1/15 Bayer Files Hemophilia A Drug Marketing Application in Japan zacks.com
• 6/29/15 Walgreen Settles Medicaid False Billing Case in New York reuters.com
• 6/25/2015 Data Shown on the Impacts of Hemophilia on Caregivers and Patients news-medical.net
• 6/25/2015 CSL Behring Presents Data from Phase I/III rVIII Single-Chain Study news-medical.net
• 6/24/2015 Novo Nordisk Presents Positive Data for the Treatment of Hemophilia A newswire.ca
• 6/24/2015 Baxalta Provides Update on Progress with Hemophilia B Gene Therapy fiercebiotech.com
• 6/24/2015 Catalyst Announces Results from Phase I Trial to Treat Hemophilia globenewswire.com
• 6/24/2015 CSL Behring Presents rIX-FP Data for Phase III trial for Hemophilia B prnewswire.com
• 6/24/2015 Alnylam Reports Data for ALN-AT3 for Treatment of Hemophilia A & B pharmiweb.com
• 6/19/2015 Quick Action Saves Teen from Stroke cbsnews.com
• 6/10/2015 Apitope's Inhibitor Drug ATX-F8-117 Granted Orphan Drug Status pharmabiz.com
• 6/2/2015 Mountaineer and Hemophiliac Chris Bombardier to Conquer Highest Summit on Each Continent purpose2play.com
• 4/30/2015 FDA Approves IXINITY from Emergent BioSolutions to Treat Hemophilia B emergentbiosolutions.com
• 4/28/2015 Merck's Grazoprevir/Elbasvir Combo cures 99% of Hep C Patients with Chronic Kidney Disease aidsmap.com
• 4/20/2015 Baxter Submits Positive Data for BAX111 to Treat von Willebrand Disease zacks.com
• 4/14/2015 CSL Behring Renews Pledge to World Federation of Hemophilia cslbehring.com
• 4/13/2015 Employees & Patients Find Joy in Giving back to the Hemophilia Community baxter.com
• 4/13/2015 RNAi Therapy Targets Antithrombin to Promote Clotting for Hemophilia A & B nature.com
• 3/26/2015 Novo Nordisk Announces US Launch of Novoeight for Hemophilia A news-medical.net
• 3/24/2015 FDA Warns of Serious Drug Interaction with Hep C Drugs Harvoni & Sovaldi FDA.gov
• 3/20/2015 New Study Finds Hemophilia Carriers Have Evidence of Joint Abnormalities CDC.gov
• 3/12/2015 One Time Dose of Gene Therapy in Animal Testing Treats Hemophilia B futurity.org
• 3/12/2015 Study Uses Gene Therapy to Produce Mutated Protein as Tool for Hemophilia medicalxpress.com
• 3/4/2015 FDA Accepts Bayer's Biologics License Application for BAY 81-8973 to Treat Hemophilia A in Children and Adults news-medical.net
• 2/27/2015 Biogen Idec & Sobi Report Positive Results from Phase III Alprolix Pediatric Study

marketwatch.com

• 2/25/2015 Acquired Hemophilia A Successfully Treated with Rituximab HFA.com &  mjhid.org
• 2/4/2015 FDA Accepts Review for CSL Behring's BLA for rIX-FP for Hemophilia B newsire.ca
• 1/30/2015 OPKO Submits to Initiate Phase 2a Trial for Long Acting Coagulation Factor VIIa-CTP to treat Hemophilia businesswire.com
• 1/29/2015 Biogen Idec, Fondazione Telethon and Ospedale San Raffaele Announce Collaboration to Develop Gene Therapies for Hemophilia pipelinereview.com
• 12/24/2014 Baxter seeks FDA Approval for BAX111 to treat Von Willebrand Disease pharmabiz.com
• 10/24/2014 FDA Approves Obizur for Treatment of Acquired Hemophilia A fda.gov
• 10/01/2014 World Thrombosis Day is October 13 worldthrombosisday.org
• 9/24/2014 NSAIDS Linked to Increased Venous Thromboembolism Risk medscape.com
• 7/17/2014 Plant Based Research Improves Hemophilia Treatment upenn.edu
• 7/16/2014 Pfizer Hemophilia B Treatment Meets Endpoint in Phase 3 Trial biospace.com
• 7/2/2014 Dr. Bernard Discusses Pediatric Stroke on Colorado Public Radio cpr.org
• 6/30/2014 NF and McMaster Univ. Collaborate on Guidelines for HTCs hemophilia.org
• 6/6/2014 FDA Approves Longer-Lasting Eloctate for Treatment of Hemophilia A bostonglobe.com
• 6/6/2014 European Commission Approves Pradaxa for Prevention of DVT and PE news-medical.net
• 5/20/2014 University of Colorado HTC joined Twitter, please follow us!
• 5/18/2014 Drug Companies Pledge Factor VIII Donation in Developing Countries healio.com
• 5/18/2014 CU Gets Grant to Study Pediatric Strokes denverpost.com
• 5/16/2014 University of Colorado HTC joined Facebook, please like our page!
• 5/12/2014 New Findings Support Less Frequent Dosing in Hemophilia B Patients Treated with Coagulation Factor IX with Recombinant Albumin (rIX-FP) pipelinereview.com
• 5/12/2014 FDA Approves Bayer's Kogenate FS Antihemophilic Factor VIII (recombinant) for Routine Prophylaxis in Adults with Hemophilia A Marketwatch.com
• 4/23/2014 Baxter Announces FDA Approval of ADVATE with BAXJECT III Reconstitution System baxter.com
• 4/10/2014 88% of Previous Relapsers Achieve Hepatitis C Cure with Simeprevir-based Triple Therapy AIDSmap.com 
• 4/9/2014 Boehringer's Pradaxa Gets FDA Approval for DVT, PE Treatment PBR
• 4/2/2014 Baxter Acquires Chatham for $70M+, Boosting it's Hemophilia Pipeline genengnews.com
• 3/28/2014 U.S. FDA approves Biogen's Hemophilia drug Alprolix Reuters.com
• 3/22/2014 Canada OKs Biogen Idec Drug for Treatment of Hemophilia B bostonglobe.com
• 3/13/2014 Stroke in Children Will be Focus of $3 M Grant at CU phys.org
• 3/7/2014 New Hemophilia Drugs Aim to Simplify Treatment Reuters.com
• ​3/1/14 March is Hemophilia Awareness Month. Find free downloads for Facebook to support those with bleeding disorders, and get the facts about Hemophilia and other bleeding disorders. hemophiliafed.org   
• 3/1/14 March is Blood Clot and Deep Vein Thrombosis Awareness Month. Find out more about DVT and blood clots and what you can do to prevent them, especially if you or your family have genetic predisposition to clots. stoptheclot.org  
• 2/12/14 Common infections linked to stroke in children; vaccines may reduce risk heart.org